The viability of serum-free cell cryopreservation solution after recovery is unstable. Please recommend a batch of stable products

The domestic serum-free cryopreservation solution I am currently using in my laboratory has a unit price of 100ml that is within your budget, and the fluctuation of MSC recovery activity rate is smaller than the one I used before. In practical use, it supports direct placement of -80 in liquid nitrogen, but it is recommended to control the cell fusion degree at 80-90% before freezing, and the density should not be too low. You can contact the manufacturer for a 20ml trial pack and request them to provide batch consistency data for MSC. We mainly consider three points when selecting: whether we have done MSC, whether we can provide stock, and whether the quality control indicators are complete. If you need the goods within a week, please inquire about the inventory and shipping city in advance, and do not get stuck in the agent transfer.

For MSC, it is recommended to choose a formulation that explicitly states support for direct transfer from -80°C to liquid nitrogen and has been validated specifically for mesenchymal stem cells. For serum-free systems, DMSO being stated as below 5% is not enough; you need to ask clearly what the alternative protective agents are. Some use trehalose, glycerol, and amino acid combinations, which are more friendly for MSC adherence recovery. During procurement, write the supply cycle into the contract, require delivery within one week, and preferably find one with a local agent. We previously used two domestic brands, and one of them showed obvious batch-to-batch osmolality fluctuations, with recovery viability dropping from 90+ to the 70s; after switching, at least the batch-to-batch fluctuation was acceptable. Do not just look at promotional brochures; ask for COA and actual measured data.

Teacher, I suggest not just looking at the brand for now. Let the supplier provide COA and key indicators for three consecutive batches: osmotic pressure pH、 Endotoxin and actual DMSO content. When there is a large difference in batches, it is often not due to differences in the main components, but rather due to osmotic pressure or pH drift after liquid preparation. After you receive it, make a small comparison between batches of MSCs of the same generation, freeze 3 tubes per batch, and look at the wall adhesion and survival rate 24 hours after resuscitation together. It is more meaningful to look at the resuscitation survival rate alone. It's better to ask them to provide actual measurement data of MSC instead of using HeLa or 293T as a substitute. There is room for domestic options within 800, but it is important to confirm the availability of stock and regional agent inventory.

Fluctuations in viability are not necessarily all caused by the cryopreservation solution. MSC passage number, degree of digestion, cryopreservation density, whether the controlled-rate freezing container was warmed back to room temperature in advance, and post-thaw centrifugation parameters can all shave off more than ten percentage points of viability. I suggest you first use the same bottle of cryopreservation solution to conduct a variable investigation: use cells from the same passage, fix the cryopreservation density and protocol, and only switch between different batches of cryopreservation solution; then check whether the storage time at 4°C or room temperature after arrival was too long. We later found that the controlled-rate freezing container in the lab had a changed cooling curve due to frost formation, and after switching back to isopropanol, the fluctuations were much smaller. Therefore, before recommending a product, first lock down these operational variables; otherwise, even the best batch will be hard to stabilize.